` Comparison: ESPR vs JNJ - Alpha Spread

ESPR
vs
JNJ

Over the past 12 months, ESPR has outperformed JNJ, delivering a return of +69% compared to the JNJ's +48% growth.

Start AI Comparison

Smart Verdict
AI-Powered

Not Sure Which Stock Wins?
Let AI Decide.
ESPR
JNJ
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
Start AI Comparison
Smart Verdict is Ready!
See Who Stands Out.
All the numbers, charts, and metrics summarized into one smart verdict.
Stocks Compared:
Show Comparison Results
Summarizing...
We need a little more time to summarize the results

Valuation Comparison

ESPR Intrinsic Value
6.27 USD
Undervaluation 56%
Intrinsic Value
Price
JNJ Intrinsic Value
176.58 USD
Overvaluation 26%
Intrinsic Value
Price
Company Last Price Intrinsic Value DCF Value Relative Value Wall St Target
Esperion Therapeutics Inc
NASDAQ:ESPR
2.76 USD
Johnson & Johnson
NYSE:JNJ
239.93 USD
No Stocks Selected

Compare the stock's valuation with its competitors.

Select Stocks to Compare
Valuation Scenario:
Bear Case
Base Case
Bull Case

Growth Comparison

Growth Over Time
ESPR, JNJ

ESPR
JNJ
Add Stock
Revenue
www.alphaspread.com
No Stocks Selected

Compare company's financials with its competitors.

Select Stocks to Compare
Company LTM Historical Growth Growth Streak % Positive Years Max Drawdown Volatility Forecasted Growth
3 Years 5 Years 10 Years 1 Year 3 Years
Esperion Therapeutics Inc
Revenue
Johnson & Johnson
Revenue

All metrics are calculated based on data from the last 10 years.

No Stocks Selected

Compare company's financials with its competitors.

Select Stocks to Compare

Profitability Comparison

Free Cash Flow
ESPR, JNJ

ESPR
JNJ
Add Stock
Free Cash Flow
www.alphaspread.com
No Stocks Selected

Compare company's free cash flow with its competitors.

Select Stocks to Compare
Company LTM Average Historical Growth FCF Margin Conversion
3 Years 5 Years 3 Years 5 Years 10 Years
Esperion Therapeutics Inc
NASDAQ:ESPR
Johnson & Johnson
NYSE:JNJ
No Stocks Selected

Compare company's free cash flow with its competitors.

Select Stocks to Compare
What is Free Cash Flow?

Gross Margin

ESPR
67.9%
JNJ
67.9%

Operating Margin

ESPR
15%
JNJ
34.8%

Net Margin

ESPR
-5.6%
JNJ
28.5%

FCF Margin

ESPR
-3.2%
JNJ
20.9%

ROE

ESPR
6.6%
JNJ
35.3%

ROA

ESPR
-5.6%
JNJ
14.2%

ROIC

ESPR
34.5%
JNJ
17.1%

ROCE

ESPR
45.9%
JNJ
24.2%

Solvency Comparison

No Stocks Selected

Compare company's equity waterfall with its competitors.

Select Stocks to Compare
Balance Sheet Comparison
No Stocks Selected

Compare company's balance sheet with its competitors.

Select Stocks to Compare

Stocks Performance

Stocks Performance
ESPR, JNJ

Loading
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Performance Gap
ESPR, JNJ

Loading
ESPR
JNJ
Difference
www.alphaspread.com

Performance By Year
ESPR, JNJ

Loading
ESPR
JNJ
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
Not Sure Which Stock Wins?
Let AI Decide
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
Start AI Comparison
Compare ESPR to other stocks
LLY
Eli Lilly and Co
More expensive
vs ESPR
ROG
Roche Holding AG
More expensive
vs ESPR
MRK
Merck & Co Inc
More expensive
vs ESPR
AZN
AstraZeneca PLC
More expensive
vs ESPR
Unlock Full Access to Alpha Spread
Create Free Account
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett